Most children who catch COVID have mild illness and recover quickly. We identified key proteins in kids who’d had severe COVID with painful inflammation or respiratory failure.
Academic rigor, journalistic flair
Articles on MIS-C
Displaying all articles
Scientists are still working to understand this rare COVID syndrome in children.
Regulators are currently reviewing the safety and efficacy data of the Pfizer vaccine for five to 11 year olds before deciding whether to approve its use in this age group.
Even kids who were asymptomatic when they had COVID-19 have developed multisystem inflammatory syndrome, a new review of hundreds of cases shows.
A rare new disease syndrome appears to be caused by an overactive immune response in children, often hitting weeks after exposure to the SARS-CoV-2 virus.
Top contributors
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Senior Lecturer; MD, Victoria University
-
Instructor in Biology, University of Winnipeg
-
Associate Professor, Pediatric Infectious Diseases, Vanderbilt University
-
Research Officer - Immunology and Translational Research, Victoria University
-
Professor of Immunology, The University of Queensland
-
Strategic Advisor, Neuroscience Trials Australia, Florey Institute of Neuroscience and Mental Health, The University of Melbourne
-
PhD Student, Murdoch Children's Research Institute
